form8k82311.htm

 

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
 
WASHINGTON, D.C.  20549
 
______________
 
 
FORM 8-K
 
______________
 

CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
DATE OF REPORT
(DATE OF EARLIEST EVENT REPORTED)
 
August 23, 2011
 
______________
 
 
ASTRO-MED, INC
(EXACT NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER)
 
______________
 
 
COMMISSION FILE NUMBER      0-13200
 

RHODE ISLAND
05-0318215
(STATE  OR OTHER JURISDICTION OF INCORPORATION OR ORGANIZATION)
(IRS EMPLOYER IDENTIFICATION NUMBER)
 
600 EAST GREENWICH AVENUE, WEST WARWICK, RI 02893
(ADDRESS OF PRINCIPAL EXECUTIVE OFFICES, INCLUDING ZIP CODE)
 
(401-828-4000)
(REGISTRANT’S TELEPHONE NUMBER, INCLUDING AREA CODE)

 


 
 
 



 
ITEM 2.02. RESULTS OF OPERATIONS AND FINANCIAL CONDITION
 
 
On August 23, 2011, Astro-Med, Inc. (the “Company”) issued a press release in which it disclosed unaudited financial information related to second quarter consolidated earnings.   A copy of the press release relating to such announcement, dated August 23, 2011, is attached hereto as Exhibit 99.1 and is incorporated herein by reference.
 
 
This information shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
 
 
ITEM 8.01. OTHER EVENTS
 
 
In August 2004, the Company’s Board of Directors approved the repurchase of up to 600,000 shares of its common stock (the “Repurchase Program”).  To date, the Company has repurchased 345,911 shares pursuant to the Repurchase Program, leaving a remaining authorization of 254,089 shares.    On August 22, 2011, the Company’s Board of Directors approved an increase in the number of shares authorized for repurchase pursuant to the Repurchase Program to 500,000 shares.
 
Under the Repurchase Program, the Company’s common stock may be purchased from time-to-time on the open market or through privately negotiated transactions. The timing and amount of the purchases will be based upon market conditions, securities law considerations and other factors. The Repurchase Program does not obligate the Company to acquire a specific number of shares in any period and may be modified, suspended, extended or discontinued at any time, without prior notice.
 
 
ITEM 9.01.  FINANCIAL STATEMENTS AND EXHIBITS
 
 
(c)           Exhibit
 
 
Exhibit no.                      Exhibit
 
 
99.1  
Press Release dated August 23, 2011
 
 
 
 
SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrants have duly caused this report to be signed on their behalf by the undersigned thereunto duly authorized.
 
  ASTRO-MED, INC.  
       
Date:  August 23, 2011
By:
/s/ Joseph P. O'Connell
  
    Joseph P. O'Connell  
    Senior Vice President, Treasurer and Chief Financial Officer  
       

 
 
 
 
 
INDEX TO EXHIBITS
 
 
 
 




Exhibit No.                             Exhibit

99.1                                          Press Release Dated August 23, 2011